Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

autologous tumor-infiltrating lymphocytes MDA-TIL

A preparation of autologous tumor-infiltrating lymphocytes (TILs) with potential antineoplastic activity. TILs are isolated from a patient’s tumor tissue, then cultured and expanded in vitro in the presence of interleukin-2 (IL-2) and an agonistic anti-4-1BB (CD137) antibody. Upon infusion of the autologous expanded TILs back into the patient, the cells specifically recognize, target, and kill the patient’s tumor cells.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	MDA autologous TILs MDA autologous tumor-infiltrating lymphocytes
Code name:	MDA-TILs

autologous tumor-infiltrating lymphocytes MDA-TIL

Search NCI's Drug Dictionary